Today
July 25, 2026Dilution Risk
5Last 7DListing Risk
37Last 30DEarnings
9Last 7DInsider / Ownership
3Last 14DDividends
1Last 30DFDA / Clinical
7Last 30DWLYN/A+0.00%
Capital Return
Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 Million
Wiley expanded its buyback allocation, making shareholder capital return the main update.
bullishImpact 65
IBRXN/A+0.00%
Strategic Transaction
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
ImmunityBio obtained exclusive U.S. rights to JBL's Tokyo-172 BCG to pursue FDA approval.
bullishImpact 68
Pharmaceuticals & BiotechnologyIndustry
Product Update
New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
Small U.S. real-world case series shows ~31% complete responses after ADSTILADRIN re-induction in BCG‑unresponsive NMIBC.
neutralImpact 55
NXXTN/A+0.00%
Earnings
Correction: NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET
NextNRG schedules Q1 2026 earnings call for May 18, 2026 at 9:00 a.m. ET.
neutralImpact 55
NBTXN/A+0.00%
FDA / Clinical
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Phase 2 Part 1 shows high response rates for JNJ-1900 (NBTXR3) in stage III unresectable NSCLC.
bullishImpact 65
UN/A+0.00%
Insider / Ownership
Director Botha granted 13,201 RSUs (Form 4)
Director Roelof Botha received 13,201 restricted stock units on 2026-05-13.
neutralImpact 55
AVXN/A+0.00%
Listing Risk
Nasdaq bid-price deficiency; compliance required by July 6, 2026
Nasdaq requires AVX to regain $1 bid price compliance by July 6, 2026; reverse split may be proposed May 29, 2026.
bearishImpact 82
WETON/A+0.00%
Dilution Risk
At-the-market sales agreement with Chaince Securities
Company entered an ATM agreement to sell ordinary shares, raising up to $17M.
bearishImpact 65
IAUXN/A+0.00%
Dilution Risk
Warrant indenture filed for up to 34,849,025 warrants
Indenture allows issuance of up to 34.85M dilutive warrants.
bearishImpact 60
VELON/A+0.00%
Dilution Risk
Entered ATM sales agreement for up to $100M of common stock
Announced up-to-$100M ATM sales agreement, enabling potential dilution.
bearishImpact 65
BURUN/A+0.00%
Listing Risk
NYSE American noncompliance notice and equity exchange for pre-funded warrants
Company faces NYSE American noncompliance and issued large exercisable pre-funded warrants.
bearishImpact 78
XTLBN/A+0.00%
Shareholder Vote
Extraordinary Meeting to Approve Psyga Acquisition, ADS Issuance, Share Increase
Shareholders vote June 22, 2026 on Psyga acquisition, significant ADS issuance, share-cap increase, and financing.
volatileImpact 80
BCLIN/A+0.00%
Earnings
Q1 2026 results; Phase 3 ENDURANCE prep and $2M financings
Q1 results: Phase 3 prep progressing, but cash runway is critically low.
volatileImpact 80
CYABN/A+0.00%
Earnings
Cyabra Reports First Quarter 2026 Results and Highlights Commercial Progress Following Nasdaq Listing
Cyabra reported Q1 ARR and revenue growth post‑Nasdaq listing, but a larger net loss from listing charges.
volatileImpact 65
BGLN/A+0.00%
Legal Risk
Blue Gold Provides Update on Cayman Islands Court Ruling in Shareholder Litigation
Cayman court kept injunction blocking Blue Gold's EGM and Article amendments, extending litigation uncertainty.
bearishImpact 62
SIEBN/A+0.00%
Earnings
Siebert Reports First Quarter 2026 Financial Results
Siebert reports Q1 revenue $23.5M; stock loan and advisory growth, but net loss $2.0M.
neutralImpact 60
LGIHN/A+0.00%
Product Update
LGI Homes Opens New Community Within Los Lunas’ Expanding Los Senderos Development
LGI Homes opens a new Los Lunas community, expanding local inventory and early buyer interest.
bullishImpact 55
NXXTN/A+0.00%
Earnings
NextNRG Reports First Quarter 2026 Financial Results
NextNRG Q1 revenue +29% YoY and gross profit tripled, yet net loss widened and cash is low.
neutralImpact 60
NXXTN/A+0.00%
Earnings
NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET
NextNRG schedules Q1 2026 earnings call for May 18, 2026 at 9:00 a.m. ET.
neutralImpact 60
MARAN/A+0.00%
Strategic Transaction
MARA Announces Expiration and Results of the Consent Solicitation for the 8.750% Senior Secured Notes due 2032 of Long Ridge Energy LLC
MARA won majority consents to amend Long Ridge notes, enabling its planned acquisition pending approvals.
bullishImpact 78